Mainz Biomed B.V.
Mainz Biomed B.V.（MYNZ）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
mynz · 股价预测 · 3 位分析师（近3月）· FMP · 更新于 2026年3月8日
分析师评级与共识
基于过去 3 个月内 3 位华尔街分析师
Hold
3 位分析师
共识
评级分布
12 个月目标价
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $2.33
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $2.33 | ↑ 0.09% |
1-day model range: $2.19–$2.48. Peak: $2.48 (+0.09%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · MYNZ · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-11-25 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2024-03-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-11-21 | Cantor Fitzgerald | Downgrade ↓ | Overweight→Neutral |
| 2023-11-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-09-26 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2023-09-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-09-14 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2023-08-22 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2023-08-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-06-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Mainz Biomed B.V. (MYNZ) stock. Of the recent 17 rating actions, 0 were upgrades and 2 were downgrades. 3 analysts currently cover MYNZ.
分析师推荐趋势
MYNZ analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$1M
↓ 64.9% YoY
Revenue Next Year
$1M
↑ 5.0% YoY
EPS This Year
$-2.86
EPS Next Year
$-0.03
↓ 99.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast MYNZ EPS of $-2.86 for the current fiscal year, based on estimates from 1 analysts. The MYNZ revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
MYNZ 股价预测由两类独立数据源支撑：来自 3 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。MYNZ 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Hold。
MYNZ 的短期预测（明日）为 $2.33（+0.09%）。
Mainz Biomed B.V. 在 NASDAQ 上市，代码 MYNZ。MYNZ 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 33% 对应 Hold 共识。
常见问题
MYNZ 预测 · 8 个问题根据 3 位华尔街分析师，MYNZ 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $2.33，隐含约 +0.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.